Your Article Summary
See Latest ArticlesBreast cancer in a male with ankylosing spondylitis treated with TNF-alpha antagonists
Joint, Bone, Spine, 06/23/09
Mansouri LE et al. - A 72-year-old male with a 4-year history of TNF-alpha antagonist therapy (infliximab and etanercept) for ankylosing spondylitis was diagnosed with breast cancer. He had a family history of breast cancer. The low incidence and considerable severity of breast cancer in males, genetic risk factors, and potential role for TNF-alpha antagonist therapy are discussed.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Can tumor necrosis factor inhibitors be safely used in pregnancy?
Journal of Rheumatology, 12/17/09
The effect of anti-TNF agent on oxidation status in patients with ankylosing spondylitis
Clinical Rheumatology, 12/17/09
Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for the M694V mutation
Journal of Rheumatology, 12/17/09
Today in Systemic Lupus (SLE)...keeping you current
Receive free subspecialty "5-minute updates" via email
A single-nucleotide polymorphism of the TNFSF4 gene is associated with systemic lupus erythematosus in Chinese Han population
Rheumatology International, 12/19/09
The role of anti-alpha-actinin antibodies in the pathogenesis and monitoring of lupus nephritis
Arthritis Research & Therapy, 12/19/09
Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of Lupus Study
Journal of Rheumatology, 12/17/09